Proficio Capital Partners LLC Purchases New Shares in Balchem Co. (NASDAQ:BCPC)

Proficio Capital Partners LLC bought a new stake in shares of Balchem Co. (NASDAQ:BCPC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 144,956 shares of the basic materials company's stock, valued at approximately $23,628,000. Proficio Capital Partners LLC owned about 0.45% of Balchem as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of BCPC. Westside Investment Management Inc. purchased a new stake in Balchem during the third quarter valued at approximately $27,000. R Squared Ltd acquired a new position in Balchem during the 4th quarter valued at approximately $29,000. Wilmington Savings Fund Society FSB acquired a new position in Balchem during the 3rd quarter valued at approximately $35,000. Venturi Wealth Management LLC acquired a new position in Balchem during the 4th quarter valued at approximately $95,000. Finally, Smartleaf Asset Management LLC increased its stake in Balchem by 230.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company's stock valued at $106,000 after purchasing an additional 450 shares in the last quarter. Hedge funds and other institutional investors own 87.91% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on BCPC. StockNews.com lowered shares of Balchem from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th. Sidoti upgraded shares of Balchem to a "hold" rating in a research note on Tuesday, February 25th. Finally, HC Wainwright restated a "buy" rating and set a $190.00 price target on shares of Balchem in a research note on Monday, February 24th.

Remove Ads

Balchem Stock Performance

Shares of NASDAQ:BCPC traded down $2.67 during midday trading on Tuesday, reaching $165.79. The company's stock had a trading volume of 125,089 shares, compared to its average volume of 110,789. The firm has a market capitalization of $5.39 billion, a PE ratio of 42.19, a P/E/G ratio of 4.41 and a beta of 0.63. Balchem Co. has a twelve month low of $137.69 and a twelve month high of $186.03. The stock has a fifty day moving average of $164.07 and a 200 day moving average of $169.70. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19.

Balchem (NASDAQ:BCPC - Get Free Report) last released its quarterly earnings data on Friday, February 21st. The basic materials company reported $1.03 earnings per share for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). The business had revenue of $240.00 million during the quarter, compared to analyst estimates of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. On average, equities analysts expect that Balchem Co. will post 4.64 EPS for the current fiscal year.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.